Genetics and Your Family's Risk
At a Glance
Fibronectin glomerulopathy may run in families through a disease-causing FN1 variant, usually with autosomal dominant inheritance. Each child of a carrier has a 50% chance of inheriting it, but symptoms may range from none to kidney failure, so genetic counseling and kidney monitoring are important.
Because Fibronectin glomerulopathy (FNG) can be a hereditary condition, your diagnosis may have implications for your parents, siblings, and children. Understanding the genetics of the disease can help your family members make informed choices about their own health monitoring [1][2].
The FN1 Gene
In a subset of genetically tested FNG cases, a pathogenic variant (a disease-causing mutation) is found in the FN1 gene, which provides the blueprint for making the fibronectin protein [3][1]. These mutations often occur in sections of the gene that help fibronectin stick to other structures in the kidney. When these “binding sites” are broken, the protein clumps together incorrectly [4][5].
If your genetic test does not find an FN1 mutation, it does not necessarily mean you don’t have the disease, nor does it establish that another undiscovered gene is responsible; the case may be sporadic [3][6]. Additionally, a “variant of uncertain significance” (VUS) should not be used to predict disease or guide family testing.
How FNG is Inherited
When FNG is familial, it typically follows an autosomal dominant inheritance pattern [7]. This means:
- A 50% Chance: If you carry a confirmed pathogenic variant, each of your children has a 50% chance of inheriting that same variant [1].
- One Copy is Enough: You only need to inherit the mutation from one parent to be at risk for the disease [1].
Reduced Penetrance and Variable Expressivity
One of the most confusing parts of FNG is variable expressivity and reduced penetrance. This means that two people in the same family with the exact same genetic variant can have very different experiences [7].
- The Asymptomatic Carrier: Some people carry the pathogenic variant but never develop any signs of kidney disease. A normal urine test, eGFR, or blood pressure today does not necessarily exclude a familial variant or future disease [1].
- Mild vs. Severe Disease: One relative might have only a tiny amount of protein in their urine, while another might develop full nephrotic syndrome or kidney failure [7].
What If No One Else in the Family Is Sick?
It is common for patients to have no known family history of kidney disease. This can happen for several reasons:
- De Novo Mutations: Sometimes a mutation happens for the first time in you. These “new” mutations have been documented in both children and adults with FNG [8][9].
- Unrecognized Disease: In the past, FNG was often misdiagnosed. A relative might have been told they had “Bright’s disease” or general “kidney inflammation” when they actually had FNG [2].
Screening and Counseling for Your Family
If you have a confirmed genetic mutation, your “first-degree” relatives (parents, siblings, and children) should be informed so they can decide about their own health monitoring. They should be offered referral to a genetic counselor [10].
- Genetic Counseling: A genetic counselor can help your family understand the risks, reproductive options, privacy considerations, age-appropriate testing for children, and how the results might affect life or disability insurance (legal protections differ by country) [11].
- Cascade Testing: This is a targeted genetic test for family members to see if they carry the specific pathogenic variant found in you. It is more accurate and often less expensive than a full genetic screen [10].
- Clinical Screening: For relatives who choose not to have genetic testing, or if no mutation was found in your case, doctors recommend simple clinical checks:
By identifying the disease early, doctors can start clinical monitoring in family members [1].
Common questions in this guide
How likely is my child to inherit fibronectin glomerulopathy?
Can fibronectin glomerulopathy still be present if my FN1 test is negative?
What should I do if my genetic report says VUS?
Should my parents, siblings, or children be tested for FNG?
Can someone have the FN1 variant without kidney symptoms?
Why might no one else in my family have fibronectin glomerulopathy?
Get notified when new evidence is published on Fibronectin glomerulopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
A Novel FN1 Nucleotide Variant c.3051G>C (p.Trp1017Cys) in a Pediatric Patient with Fibronectin Glomerulopathy: Case Report and Literature Review.
Sun L, Kuang X, Wu Y, Huang W
Journal of clinical medicine 2026; (15(13)) doi:10.3390/jcm15135016.
PMID: 42452483 - 2
Fibronectin glomerulopathy in a kidney allograft biopsy.
Klair N, Mahmood SB, El-Rifai R, et al.
BMC nephrology 2023; (24(1)):359 doi:10.1186/s12882-023-03403-y.
PMID: 38053039 - 3
A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family.
Dos Reis Monteiro MLG, Custódio FB, de Menezes Neves PDM, et al.
BMC nephrology 2019; (20(1)):322 doi:10.1186/s12882-019-1507-7.
PMID: 31419955 - 4
Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits.
Ohtsubo H, Okada T, Nozu K, et al.
Pediatric nephrology (Berlin, Germany) 2016; (31(9)):1459-67 doi:10.1007/s00467-016-3368-7.
PMID: 27056061 - 5
Detection of a Splice Site Variant in a Patient with Glomerulopathy and Fibronectin Deposits.
Tsuji Y, Nozu K, Sofue T, et al.
Nephron 2018; (138(2)):166-171 doi:10.1159/000484209.
PMID: 29131116 - 6
Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.
Takii M, Suehiro T, Shima A, et al.
BMC nephrology 2017; (18(1)):288 doi:10.1186/s12882-017-0704-5.
PMID: 28877681 - 7
Clinicopathological features of familial fibronectin glomerulopathy caused by a splice site variant in the Fibronectin 1 gene: a case report.
Nagayama Y, Otani M, Hashimoto M, et al.
CEN case reports 2025; (14(3)):351-357 doi:10.1007/s13730-025-00987-2.
PMID: 40120032 - 8
Rapidly progressive pediatric fibronectin glomerulopathy driven by a novel FN1 mutation (p.Thr1917del): implications for early diagnosis and recognition of systemic involvement.
Chen X, Huang J, Chen Y, et al.
Pediatric nephrology (Berlin, Germany) 2026; (41(10)):3409-3422 doi:10.1007/s00467-026-07298-3.
PMID: 42068364 - 9
A case of unexpected diagnosis of fibronectin glomerulopathy with histological features of membranoproliferative glomerulonephritis.
Hata M, Mori T, Hirose Y, et al.
BMC nephrology 2024; (25(1)):25 doi:10.1186/s12882-024-03456-7.
PMID: 38254040 - 10
Tips for Testing Adults With Suspected Genetic Kidney Disease.
Savige J
American journal of kidney diseases : the official journal of the National Kidney Foundation 2024; (83(6)):816-824 doi:10.1053/j.ajkd.2023.10.011.
PMID: 38147894 - 11
Genetic Counseling in Kidney Disease: A Perspective.
Stein Q, Westemeyer M, Darwish T, et al.
Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.
PMID: 37334143 - 12
Alport Syndrome Family Screening and Management: Experience of a Tertiary Center.
Gomes AM, Reis CF, Dias J, et al.
Kidney medicine 2026; (8(8)):101419 doi:10.1016/j.xkme.2026.101419.
PMID: 42529192
This page is for informational purposes only and does not constitute medical advice. A nephrologist and genetic counselor can help your family interpret FN1 results and plan appropriate screening.